Prevention of travel-associated tuberculosis in the high-risk traveler [6]

Clinical Infectious Diseases

Volumn 34, Issue 8, 2002, Pages 1163-

  Lifson, Alan R ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; ISONIAZID;

ENDEMIC DISEASE; HIGH RISK POPULATION; HUMAN; INCIDENCE; INFECTION RISK; LETTER; LIVER TOXICITY; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; TRAVEL; TUBERCULIN TEST; TUBERCULOSIS;

ANTI-BACTERIAL AGENTS; HUMANS; TRAVEL; TUBERCULIN TEST; TUBERCULOSIS;

EID: 0037090202     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/339757     Document Type: Letter

References (7)

1. Risk of travel-associated tuberculosis
2. Mycobacterium tuberculosis infection in travellers: Tuberculosis comes home
3. Risk of infection with Mycobacterium tuberculosis in travellers to areas of high tuberculosis endemicity
4. Targeted tuberculin testing and treatment of latent tuberculosis infection
5. Comparison of a whole-blood interferon γ assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection
6. Diagnostic standards and classification of tuberculosis in adults and children
7. Lifetime risks, incubation period, and serial interval of tuberculosis